These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 39355653)

  • 1. Modified Ce/Zr-MOF Nanoparticles Loaded with Curcumin for Alzheimer's Disease via Multifunctional Modulation.
    Yang Y; Wang Y; Jiang X; Mi J; Ge D; Tong Y; Zhu Y
    Int J Nanomedicine; 2024; 19():9943-9959. PubMed ID: 39355653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional Nanocarrier for Synergistic Treatment of Alzheimer's Disease by Inhibiting β-Amyloid Aggregation and Scavenging Reactive Oxygen Species.
    Wang C; Song X; Li P; Sun S; Su J; Liu S; Wei W
    ACS Appl Mater Interfaces; 2024 May; 16(21):27127-27138. PubMed ID: 38747495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuron tau-targeting biomimetic nanoparticles for curcumin delivery to delay progression of Alzheimer's disease.
    Gao C; Chu X; Gong W; Zheng J; Xie X; Wang Y; Yang M; Li Z; Gao C; Yang Y
    J Nanobiotechnology; 2020 May; 18(1):71. PubMed ID: 32404183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal mitochondria-targeted therapy for Alzheimer's disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems.
    Han Y; Chu X; Cui L; Fu S; Gao C; Li Y; Sun B
    Drug Deliv; 2020 Dec; 27(1):502-518. PubMed ID: 32228100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer's disease.
    Meng F; Asghar S; Gao S; Su Z; Song J; Huo M; Meng W; Ping Q; Xiao Y
    Colloids Surf B Biointerfaces; 2015 Oct; 134():88-97. PubMed ID: 26162977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
    Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
    Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation of lactoferrin decorated dextran based chitosan-coated europium metal-organic framework for targeted delivery of curcumin.
    Nangare S; Ramraje G; Patil P
    Int J Biol Macromol; 2024 Feb; 259(Pt 2):129325. PubMed ID: 38219935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self- assembled lactoferrin-conjugated linoleic acid micelles as an orally active targeted nanoplatform for Alzheimer's disease.
    Agwa MM; Abdelmonsif DA; Khattab SN; Sabra S
    Int J Biol Macromol; 2020 Nov; 162():246-261. PubMed ID: 32531361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte membrane-coated nanocarriers modified by TGN for Alzheimer's disease.
    Gu J; Yan C; Yin S; Wu H; Liu C; Xue A; Lei X; Zhang N; Geng F
    J Control Release; 2024 Feb; 366():448-459. PubMed ID: 38128884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective Potential of Curcumin-Loaded Nanostructured Lipid Carrier in an Animal Model of Alzheimer's Disease: Behavioral and Biochemical Evidence.
    Sadegh Malvajerd S; Izadi Z; Azadi A; Kurd M; Derakhshankhah H; Sharifzadeh M; Akbari Javar H; Hamidi M
    J Alzheimers Dis; 2019; 69(3):671-686. PubMed ID: 31156160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin alleviates Alzheimer's disease by inhibiting inflammatory response, oxidative stress and activating the AMPK pathway.
    Shao S; Ye X; Su W; Wang Y
    J Chem Neuroanat; 2023 Dec; 134():102363. PubMed ID: 37989445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Nanozyme-Boosted MOF-CRISPR Platform for Treatment of Alzheimer's Disease.
    Yang J; Qin G; Liu Z; Zhang H; Du X; Ren J; Qu X
    Nano Lett; 2024 Aug; 24(32):9906-9915. PubMed ID: 39087644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Porphyrinic Metal-Organic Framework PCN-224 Nanoparticles for Near-Infrared-Induced Attenuation of Aggregation and Neurotoxicity of Alzheimer's Amyloid-β Peptide.
    Wang J; Fan Y; Tan Y; Zhao X; Zhang Y; Cheng C; Yang M
    ACS Appl Mater Interfaces; 2018 Oct; 10(43):36615-36621. PubMed ID: 30338980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aβ
    Zhang L; Cao K; Xie J; Liang X; Gong H; Luo Q; Luo H
    J Nanobiotechnology; 2024 May; 22(1):278. PubMed ID: 38783363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-situ growth of CeO
    Chi M; Liu J; Li L; Zhang Y; Xie M
    Colloids Surf B Biointerfaces; 2024 Jun; 238():113887. PubMed ID: 38581835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer's disease.
    Fan S; Zheng Y; Liu X; Fang W; Chen X; Liao W; Jing X; Lei M; Tao E; Ma Q; Zhang X; Guo R; Liu J
    Drug Deliv; 2018 Nov; 25(1):1091-1102. PubMed ID: 30107760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin nanoparticles in heat stroke management.
    Guo F; Wu Y; Liu J
    J Nanobiotechnology; 2024 Sep; 22(1):559. PubMed ID: 39267043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring Curcumin-Loaded Lipid-Based Nanomedicine as Efficient Targeted Therapy for Alzheimer's Diseases.
    Far BF; Safaei M; Pourmolaei A; Adibamini S; Shirdel S; Shirdel S; Emadi R; Kaushik AK
    ACS Appl Bio Mater; 2024 Jun; 7(6):3535-3555. PubMed ID: 38768054
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Zhang L; Yang S; Wong LR; Xie H; Ho PC
    Mol Pharm; 2020 Nov; 17(11):4256-4269. PubMed ID: 33084343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal administration of dauricine loaded on graphene oxide: multi-target therapy for Alzheimer's disease.
    Wang K; Wang L; Chen L; Peng C; Luo B; Mo J; Chen W
    Drug Deliv; 2021 Dec; 28(1):580-593. PubMed ID: 33729067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.